Blood Stream Infections

General information

Significant blood stream infections will be followed up the next day by a Consultant Microbiologist, either by telephone or in person; they will discuss a treatment plan with the clinical team.

RAST (rapid antimicrobial susceptibility testing): Blood cultures that are newly positive before 12.00 now have identification and limited susceptibilities available on the same day, and a full report on the next day. In these circumstances, the following comment on reports will be seen: "This positive blood culture is suitable for rapid testing. A further report will be available between 8pm and 9pm this evening."

Management of newly positive blood cultures

Four management algorithms are available (see here), divided into:

  • Gram positive cocci: likely staphylococcus;
  • Gram positive cocci: likely streptococcus;
  • Gram negative rod / bacillus, and
  • Yeast.

It can sometimes be difficult to differentiate gram positive cocci into staphylococci or streptococci on microscopy. In such situations, please refer to both flowcharts.

A Consultant Microbiologist is available for advice (see Appendix 6 for contact details) if recommended antimicrobials are inappropriate for the patient or if the management of the patient remains unclear.  

Organism specific management

S. aureus bacteraemia (SAB)

Follow the Scottish Antimicrobial Prescribing Group (SAPG) algorithm for the treatment of suspected or proven SAB.

All cases of proven SAB are followed up by a consultant microbiologist, and a management plan will be communicated to the patient's clinical team.

S. aureus bacteraemia can occur in the context of a variety of infections with S. aureus, such as:

  • infective endocarditis
  • skin and soft tissue infections
  • pneumonia
  • device-related infections, including:
    • peripheral venous catheter (PVC) infection
    • central venous catheter (CVC) infection
    • prosthetic joint infection
    • cardiac device infection

In turn, SAB can lead to serious metastatic infections, including:

  • infective endocarditis
  • solid organ abscesses
  • metastatic bone and joint infection, including spondylodiscitis and infections of orthopaedic hardware
  • metastatic device-related infections, e.g. permanent cardiac pacemakers, vascular grafts

SAB is associated with a mortality of up to 30%, and recurrence is seen in approximately 10% of cases.

Candidaemia

Blood stream infections with candida species are a significant event that is associated with a mortality of up to 47%; if the patient presents with septic shock mortality rates are even higher.

Patients with significant comorbidities and who have received (prolonged) broad spectrum antimicrobials are at particular risk of candidaemia.

Mortality is closely linked to timing of therapy and source control - the earlier appropriate therapy is started and implicated foreign material, such as central venous access catheters are removed or infected collections are drained, the better the chances of survival.

If candida is isolated from a blood culture, this should not be regarded as a contaminant.

A consultant microbiologist will follow up all cases of candidaemia and advise on specific antifungal therapy and other aspects of management.

Remove all central venous catheters in non-neutropenic patients.

All patients should be referred to ophthalmology for funduscopic examination - candida endophthalmitis is a sight-threatening complication of candidaemia. 

Patients should be treated for at least 14 days from the next negative blood culture - longer therapy may be required depending on the source and possible complications. 

Patients with persistent candidaemia and those with prosthetic heart valves should have an echocardiogram to rule out infective endocarditis.

For further information, refer to this IDSA guideline.

Gram negative bacteraemia

Blood stream infections with gram negative bacilli/rods are often associated with intra-abdominal or urinary tract infections, although other sources are possible (e.g. vascular access device, hospital-acquired pneumonia); the most commonly isolated organism is Escherichia coli.

The initial treatment should be with an intravenous antimicrobial.

Please note that almost 70% of E. coli isolated from blood cultures in NHS Ayrshire & Arran are resistant to amoxicillin - this agent is only recommended for treatment if amoxicillin susceptibility has been confirmed.

Gentamicin should be avoided in patients with decompensated liver disease (jaundice, ascites, encephalopathy, variceal bleeding or hepato-renal syndrome).

Sampling for suspected vascular access device infections

Condition Samples to send Comments

Suspected peripheral vascular catheter (PVC) site infection

  • Blood culture if sepsis criteria are fulfilled
  • Swab (black) from PVC site

Remove PVC if infection is suspected

Suspected central vascular access device infection

  • Blood cultures from a peripheral venipuncture first, then from the line immediately afterwards
  • Swab (black) from exit site
  • Further blood cultures from periphery and line

Differential time to positivity can help establishing whether source of bacteraemia is the access device, or whether a systemic bacteraemia from another source is present

 

 

Page last updated: February 2024

 




;